Gene therapy particles aim to boost stroke recovery
Disease control
Recruiting now
This early-stage trial tests a new drug called SNE-101 in people who have had an acute ischemic stroke within the past five days. The main goal is to see if SNE-101 is safe and tolerable, and to find the highest safe dose. The study also looks at whether SNE-101 can improve motor…
Phase: PHASE1 • Sponsor: S&Ebio Co. Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC